CSC Niche and Hypoxia

The microenvironment, or niche, of cancer stem cells (CSCs) plays a pivotal role in maintaining their stemness and promoting tumor growth. Hypoxia, or low oxygen levels, is a critical feature of the CSC niche that drives their survival and resistance to therapies. This track examines how hypoxia-induced signaling pathways, such as HIF-1α, enhance CSC stemness and contribute to metastasis. Researchers aim to develop strategies to disrupt the hypoxic niche, thereby sensitizing CSCs to chemotherapy and radiation. Understanding the unique features of the CSC niche can help identify new therapeutic targets that prevent CSCs from thriving under stress conditions, improving treatment outcomes.

    Related Conference of CSC Niche and Hypoxia

    February 05-06, 2026

    11th World Conference on Breast and Cervical Cancer

    Paris, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 09-10, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    March 30-31, 2026

    26th World Congress on Cancer and Diagnostics

    London, UK
    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    June 23-24, 2026

    27th World Congress on Cancer Summit

    Paris, France
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    September 29-30, 2026

    5th Experts Meeting on Cancer Medicine, Radiology & Treatment

    Aix-en-Provence, France

    CSC Niche and Hypoxia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in